| EPC377 | Examining the use of HIV self-testing to support PrEP initiation and continuation: a systematic literature review | E-poster | HIV self-testing |
| OAA0205 | Exceptional post-treatment control associated with strong NK and Ï?É? cytotoxic T cells | Oral abstract session with live Q&A | Immune mechanisms of natural or post-treatment control |
| PESAA09 | Excess BAFF alters the Breg potential of human marginal zone B-cells in the context of HIV-1 infection | Poster exhibition | Systemic immune activation and inflammation |
| EPC376 | Expanding free HIV Self-Testing (HIVST) with community health-based follow-up in New York City | E-poster | HIV self-testing |
| EPC396 | Expanding index testing to social networks among female sex workers in Burundi | E-poster | HIV testing to support identification of new cases of people living with HIV |
| OAE0203 | Expanding role of village health workers in Lesotho: from supporting HIV patients to COVID-19 contact tracing | Oral abstract session with live Q&A | Optimizing HIV services (prevention, testing and/or treatment) in the COVID-19 era |
| EPE162 | Expanding three-month drug distribution eligibility in Mozambique: impacts on viral load suppression and long-term retention | E-poster | Differentiated service delivery for HIV testing, prevention and treatment |
| EPLBE10 | Expanding viral load coverage in the pursuit of HIV epidemic control in Lualaba province in the Democratic Republic of Congo | E-poster | Approaches to viral load monitoring at scale |
| PESUE30 | Expedited development and registration resulting in successful uptake of generic, pediatric dolutegravir products for low- and middle-income countries through an innovative public-private partnership | Poster exhibition | Public-private partnerships |
| EPE271 | Experience of creating LGBTQ Welcoming Space across various HIV health care systems | E-poster | Approaches to supporting resilient health systems |